NUZ-001, an investigational oral therapy for ALS, is officially the ninth compound to be included in the HEALEY ALS platform ...

The close of the brief wreath-making season reminds columnist Kristin Neva how much different it is than being a long-term ...

Last year's intention "to be" made keeping a regular routine difficult for columnist Dagmar Munn, who intends now to live in ...

The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...

Qalsody is one step closer to being covered by public Canadian healthcare systems when used to treat adults with ALS with ...

Researchers have developed a novel approach to detect ALS and predict survival by measuring genetic activity in blood cells, a study found.